Safety and immunogenicity of a bivalent haemophilus influenzae type b/hepatitis B vaccine in healthy infants

Pediatric Infectious Disease Journal

Volumn 16, Issue 6, 1997, Pages 593-599

  West, David J ^a   Hesley, Teresa M ^a   Jonas, Leslie C ^a   Feeley, Louisa K ^a   Bird, Steven R ^a   Burke, Pamela ^a   Sadoff, Jerald C ^a   Bromberg, Kenneth ^a   Chartrand, Stephen ^a   Johnson, Donald ^a   Keyserling, Harry ^a   Petersen, Kenneth ^a   Rabalais, Gerard ^a   Reisinger, Keith ^a   Rothstein, Edward ^a   Seto, Dexter ^a   Sullivan, Bradley ^a   Watson, Barbara ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Combination vaccines; Haemophilus influenzae type b; Haemophilus influenzae type b vaccine; Hepatitis B; Hepatitis B vaccine

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERANCE; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFANT; INFECTION PREVENTION; MULTICENTER STUDY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTIBODIES, BACTERIAL; FEMALE; HAEMOPHILUS VACCINES; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INFANT; MALE; PENTOSEPHOSPHATES; POLYSACCHARIDES, BACTERIAL;

EID: 8244221661     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199706000-00010     Document Type: Article

References (38)

1. Centers for Disease Control. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease. MMWR 1985;34:201-5.
2. Hay JW, Daum RS. Cost-benefit of two strategies for prevention of Haemophilus influenzae type b infection. Pediatrics 1987;80:319-29.
3. Kane MA. Progress on the control of hepatitis B infection through immunisation. Gut 1993;34(Suppl 2):s10-12.
4. Maynard JE, Kane MA, Alter MA, Hadler SC. Control of hepatitis B by immunization: global perspectives. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Liss, 1988:967-9.
5. Centers for Disease Control. Haemophilus b conjugate vaccines for the prevention of Haemophilus influenzae type b disease among infants and children two months of age and older: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-1):1-7.
6. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
7. Sitrin RD, Wampler DE, Ellis RW. Survey of licensed hepatitis B vaccines and their production processes. In: Ellis RW, ed. Hepatitis B vaccines in clinical practice. New York: Dekker, 1993:83-101.
8. West DJ. Scope and design of hepatitis B vaccine clinical trials. In: Ellis RW, ed. Hepatitis B vaccines in clinical practice. New York: Dekker, 1993;159-77.
9. Committee on Infectious Diseases. Haemophilus influenzae type b conjugate vaccines: recommendations for immunization of infants and children 2 months of age and older: update. Pediatrics 1991;88:169-72.
10. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-13):1-25.
11. Committee on Infectious Diseases. Universal hepatitis B immunization. Pediatrics 1992;89:795-800.
12. Calandra GB, West DJ. Recommendations for prevention of hepatitis B with vaccine. In: Ellis RW, ed. Hepatitis B vaccines in clinical practice. New York: Dekker, 1993;1-16.
13. West DJ, Margolis HS. Prevention of hepatitis B virus infection in the United States: a pediatric perspective. Pediatr Infect Dis J 1992;11:866-74.
14. Käyhty H, Peltola H, Karanko V, Mäkelä H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
15. Anderson P. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1984;149:1034-5.
16. Robbins JB, Parke JC Jr, Schneerson R, Whisnant JK. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res 1973;7:103-10.
17. Vella PP, Staub JM, Armstrong J, et al. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB®). Pediatrics 1990;85(Suppl):668-75.
18. Szmuness W, Stevens CE, Zang EA, et al. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1981;1:377-85.
19. Francis DP, Hadler SC, Thompson SE, et al. The prevention of hepatitis B with vaccine: report of the Center for Disease Control multi-center efficacy trial among homosexual men. Ann Intern Med 1982;97:362-6.
20. Coutinho RA, Lelie N, Albrecht-Van Lent P, et al. Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial. Br Med J 1983;286:1305-8.
21. Centers for Disease Control. Recommendations of the Immunization Practices Advisory Committee: update on hepatitis B prevention. MMWR 1987;36:353-60, 366.
22. International Group. Immunisation against hepatitis B. Lancet 1988;1:875-6.
23. World Health Organization. Informal consultation on quadrivalent diphtheria-tetanus-pertussis-hepatitis B vaccine: final report. Geneva: WHO, 1992.
24. Hollinger FB, Adam E, Heiberg D, Melnick JL. Response to hepatitis B vaccine in a young adult population. In: Szmuness W, Alter HJ, Maynard JE, eds. Viral hepatitis: 1981 international symposium. Philadelphia: Franklin Institute Press, 1982:451-66.
25. Koch GG, Edwards S. Clinical efficacy trials with categorical data. In: Peace KE, ed. Biopharmaceutical statistics for drug development. New York: Dekker, 1988:403-57.
26. Santosham M, Wolff M, Reid R, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991;324: 1767-72.
27. Granoff DM, Holmes SJ, Osterholm MT, et al. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 1993;168: 663-71.
28. Seto D, Diwan A, Hesley T, et al. Hepatitis B vaccine alternative schedules in healthy babies of non-carrier (HB-sAg-) mothers. Pediatr Res 1992;31(4 Pt 2):179A.
29. Froehlich H. HBV vaccine for infants with an alternate schedule. Pediatr Res 1992;31(4 Pt 2):92A.
30. West DJ, Calandra GB, Ellis RW. Vaccination of infants and children against hepatitis B. Pediatr Clin North Am 1990;37: 585-601.
31. Somsak L, Preyapan S, Sriluck S, et al. A randomized comparative study of two different doses of H-B-VAX II vaccine (2.5 and 5 μg) in neonates. Thai J Pediatr 1991;30: 8-11.
32. Basaca-Sevilla V, Torres C, Cruz B, et al. A report on the use of recombinant hepatitis B vaccine in newborns and young adults in the Philippines. Filip Fam Physician 1991;29:21-9.
33. Lozano C, Del Rio A, Manzanares MC, et al. Hepatitis B vaccination of 2367 newborns with different antigenic dosages: influence of peri-natal factors on the immune response to the vaccine [Abstract]. In: Thirty-fourth Interscience Conference on Antimicrob Agents and Chemotherapy, Orlando, FL, October 4 to 7, 1994. Washington, DC: American Society for Microbiology, 1994:103.
34. West DJ, Calandra GB, Hesley TM, et al. Control of hepatitis B through routine immunization of infants: the need for flexible schedules and new combination vaccine formulations. Vaccine 1993;11(Suppl 1):s21-7.
35. Keyserling HL, West DJ, Hesley TM, et al. Antibody responses of healthy infants to a recombinant hepatitis B vaccine administered at two, four, and twelve or fifteen months of age. J Pediatr 1994;125:67-9.
36. Reisinger KS, Blatter MM, Hesley TM, et al. Immunogenicity of recombinant hepatitis B vaccine in healthy infants using three vaccination schedules. Pediatr Res 1993;33(4 Pt 2): 179A.
37. West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 1996;14:1019-27.
38. West DJ, Hesley TM, Jonas LC, et al. Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Pediatr Res 1994;35(4 Pt 2):17A.